Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
Open Access
- 1 March 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 21 (3) , 309-317
- https://doi.org/10.1111/j.1365-2125.1986.tb05195.x
Abstract
The present study was designed to investigate the effects of salicylate on the antiplatelet action of acetylsalicylic acid as well as on in vivo prostanoid formation and platelet function in healthy volunteers. In the first study six female volunteers received 350 mg acetylsalicylic acid intravenously, with and without previous oral administration of sodium salicylate (1200 mg daily for 3 days). Urinary prostanoid excretion as well as platelet aggregation and thromboxane formation were measured before and during salicylate and after acetylsalicylic acid. In the second study seven female volunteers received sodium salicylate (52.6 mg kg‐1) or acetylsalicylic acid (60.7 mg kg‐1) for 8 days in a randomized cross‐over protocol. Urinary prostanoid excretion, platelet aggregation and thromboxane formation as well as salicylate plasma concentrations were determined before, during and after administration of each drug. Sodium salicylate did not impair the complete suppression of arachidonic acid‐induced platelet thromboxane formation and aggregation obtained by the single intravenous dose of acetylsalicylic acid in the first study. Sodium salicylate in the second study did not affect urinary excretion of prostaglandin E2, its major urinary metabolite (7 alpha‐hydroxy‐5,11‐ diketo‐tetranor‐prostane‐1,16‐dioic acid), and 2,3‐dinor‐6‐keto‐ prostaglandin F1 alpha, the main urinary metabolite of epoprostenol (prostacyclin, PGI2). In contrast, acetylsalicylic acid significantly decreased excretion rates of these prostanoids by 64, 59 and 61%, respectively. In both studies platelet aggregation and thromboxane formation induced by collagen, thrombin or arachidonic acid were not significantly affected by salicylate administration, whereas acetylsalicylic acid inhibited platelet aggregation induced by all three agents as well as thrombin‐ and arachidonic acid induced thromboxane formation.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 51 references indexed in Scilit:
- A stable isotope method for the quantification ofN-acetyl-5-aminosalicylic acid in plasma and urineJournal of Mass Spectrometry, 1984
- The role of phospholipase C in platelet responsesLife Sciences, 1983
- Mikropräparation ringdeuterierter prostaglandineJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- Metabolic disposition of prostaglandin E1 in manBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- SALICYLATE INHIBITION OF ANTIPLATELET EFFECT OF ASPIRINThe Lancet, 1981
- Non-interference by salicylate with aspirin inhibition of arterial thrombosis in ratsProstaglandins and Medicine, 1981
- Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activityProstaglandins and Medicine, 1979
- Aspirin, salicylate and prostaglandinsInflammation Research, 1979
- Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the ratJournal of Pharmacy and Pharmacology, 1978
- Inhibition of prostaglandin synthesis in manBiochemical and Biophysical Research Communications, 1972